Publicações em revistas com arbitragem científica

1 Terrasso AP, Pinto C, Serra M, Filipe A, Almeida S, Ferreira AL, et al. Novel scalable 3D cell based model for in vitro neurotoxicity testing: Combining human differentiated neurospheres with gene expression and functional endpoints. J Biotechnol 2015 Jul 10;205:82-92.
Disponível em: http://www.sciencedirect.com/science/article/pii/S0168165614010475

2 Filipe A, Almeida S, Pedroso PF, Neves R, Marques S, Sicard E, et al. Single-dose, randomized, open-Label, two-Way, crossover bioequivalence study of two formulations of pregabalin 300 mg hard capsules in healthy volunteers under fasting conditions. Drugs R D 2015 Jun;15(2):195-201.
Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488182/

3 Filipe A, Pedroso P, Almeida S, Neves R, Boudreault S. Bioequivalence study of two formulations of ibandronic acid 150-mg film-coated tablets in healthy volunteers under fasting conditions: a randomized, open-label, three-way, reference-replicated crossover study. Drugs R D 2014 Jun;14(2):105-12.
Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070455/

4 Morais M, Santos PA, Mateus-Pinheiro A, Patrício P, Pinto L, Sousa N, et al. The effects of chronic stress in hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition. J Psychopharmacol 2014 Dec;28(12):1178-83.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/25315831

5 Pedroso P, Almeida S, Filipe A, Neves RI, Boudreault S, Jiménez C. Bioequivalence studies for two different strengths of montelukast in healthy volunteers: 10 mg film-coated tablets and 5 mg chewable tablets. Drug Res (Stuttg). 2013 Sep;63(9):477-483.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/23780502

6 Almeida S, Pedroso P, Filipe A, Neves RI, Tanguay M, Torns A. Bioequivalence of two formulations of escitalopram. Arzneimittelforschung 2012 Jul;62(7):307-12.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/22628062

7 Branco JC, Tomé AM, Cruz MR, Filipe A. Pirlindole in the treatment of depression and fibromyalgia syndrome. Clin Drug Investig 2011 Oct;31(10):675-89.
Disponível em: http://link.springer.com/article/10.2165%2F11595410-000000000-00000

8 Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf 2011 Jun 1;34(6):465-88.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/21585220

9 Almeida S, Pedroso P, Filipe A, Pinho C, Neves R, Jiménez C, et al. Study on the bioequivalence of two formulations of eplerenone in healthy volunteers under fasting conditions: data from a single-center, randomized, single-dose, open-label, 2-way crossover bioequivalence study. Arzneimittelforschung 2011;61(3):153-159.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/21528639

10 Almeida S, Filipe A, Neves R, Pinho C, Pedroso P, Castillo A, et al. Truncated areas under the curve in the assessment of pioglitazone bioequivalence: data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions. Arzneimittelforschung 2011;61(1):32-9.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/21355444

11 Macedo A, Leiria E, Filipe A. Pirlindole in the treatment of depression - a meta-analysis. Clin Drug Investig 2011;31(1):61-71.
Disponível em: http://link.springer.com/article/10.2165/11586690-000000000-00000/fulltext.html

12 Neves R, Almeida S, Filipe A, Franco Spínola AC, Abolfathi Z, Lévesque A, et al. Bioequivalence studies of two different film-coated tablet formulations of valacyclovir of two different strengths in healthy volunteers. Arzneimittelforschung 2010;60(5):273-81.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20533765

13 Almeida S, Filipe A, Neves R, Desjardins I, Shink E, Castillo A. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve: a single-center, single-dose, randomized, open-label, 2-way cross-over under fasting conditions. Arzneimittelforschung 2010;60(3):116-23.
Disponível em: http://www.ecv.de/download/download/Zeitschriften/ArzneimForsch/volltext/af_S00116-00123_33-Almeida.pdf

14 Almeida S, Filipe A, Neves R, Franco Spínola AC, Tanguay M, Ortuño J, et al. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects. Clin Ther 2010 Mar;32(3):556-74.
Disponível em: http://www.sciencedirect.com/science/article/pii/S0149291810000998

15 Franco Spínola AC, Almeida S, Filipe A, Neves R, Abolfathi Z, Yritia M, et al. Comparative bioavailability of two formulations of sibutramine. Int J Clin Pharmacol Ther 2009 Oct;47(10):627-37.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19825326

16 Franco Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Clin Ther 2009 Sep;31(9):1991-2001.
Disponível em: http://www.sciencedirect.com/science/article/pii/S0149291809003142

17 Filipe A, Almeida S, Franco Spínola AC, Neves R, Tanguay M, Jiménez C, et al. Single-dose randomized, open-label, 2-way crossover bioequivalence study of clopidogrel 75 mg tablet in healthy volunteers under fasting conditions. Int J Clin Pharmacol Ther 2009 Mar;47(3):187-94.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19281728

18 Franco Spínola AC, Almeida S, Filipe A, Neves R, Tanguay M, Yritia M. Bioequivalence of two formulations of levetiracetam. Int J Clin Pharmacol Ther 2008 Nov;46(11):591-96.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19000558

19 Filipe A, Almeida S, Franco Spínola AC, Neves R, Trabelsi F, Torns A, et al. Bioequivalence study of two enteric-coated formulations of pantoprazole in healthy volunteers under fed conditions. Arzneimittelforschung 2008;58(9):451-6.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18972875

20 Filipe A, Almeida S, Franco Spínola AC, Trabelsi F, Ortuño J. Bioequivalence study of two letrozole tablet formulations. Single dose, randomized, open-label, 2-way crossover bioequivalence study of letrozole 2.5 mg tablets in healthy volunteers under fasting conditions. Arzneimittelforschung 2008;58(8):419-22.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18807583

21 Neves R, Almeida S, Filipe A, Franco Spínola AC, Abolfathi Z, Yritia M, et al. Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers. Arzneimittelforschung 2008;58(8):369-75.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18807576

22 Tomé A, Filipe A. Farmacovigilância. Boletim do HPV. 2008 Janeiro/Março;XXI(1):13-17.

23 Franco Spínola AC, Almeida S, Filipe A, Tanguay M, Yritia M. Bioequivalence study of two tablet formulations of sildenafil. Arzneimittelforschung 2008;58(3):122-5.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18488808

24 Almeida S, Spínola AC, Filipe A, Trabelsi F, Farré A. Truncated AUCs in the assessment of the bioequivalence of topiramate, a long half-life drug. Arzneimittelforschung 2007;57(5):249-53.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17598694

25 Almeida S, Almeida A, Filipe A, Penedo C, Rocha A, Lainesse A, et al. In vitro disintegration and dissolution and in vivo bioequivalence of two alendronate once-weekly formulations. Arzneimittelforschung 2006;56(2):84-9.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16572922

26 Almeida S, Filipe A, Almeida A, Antonijoan R, Garcia-Gea C, Gich I, et al. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers. Arzneimittelforschung 2006;56(2):59-63.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16572918

27 Almeida S, Filipe A, Almeida A, Gich I, Antonijoan R, Puntes M, et al. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers. Arzneimittelforschung 2006;56(2):70-5.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16572920

28 Almeida S, Filipe A, Almeida A, Wong H, Caparrós N, Tanguay M. Comparative bioavailability of two formulations of levofloxacin and effect of sex on bioequivalence analysis. Data from a randomised, 2 x 2 crossover trial in healthy volunteers. Arzneimittelforschung 2005;55(7):414-9.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16080281

29 Abad-Santos F, Novalbos J, Gálvez-Múgica MA, Gallego-Sandín S, Almeida S, Vallée F, et al. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study. Pharmacol Res 2005 May;51(5):445-52.
Disponível em: http://www.sciencedirect.com/science/article/pii/S1043661804002890

30 Almeida S, Portolés A, Terleira A, Filipe A, Cea E, Cruz Caturla M. Comparative bioavailability/bioequivalence of two different sertraline formulations: a randomised, 2-period x 2-sequence, crossover, clinical trial in healthy volunteers. Arzneimittelforschung 2005;55(4):191-7.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15901041

31 Almeida A, Almeida S, Filipe A, Gagnon S, Mirapeix A, Girard B, et al. Bioequivalence study of two different coated tablet formulations of finasteride in healthy volunteers. Arzneimittelforschung 2005;55(4):218-22.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15901045

32 Portolés A, Filipe A, Almeida S, Terleira A, Vallée F, Vargas E. Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers. Arzneimittelforschung 2005;55(4):212-7.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15901044

33 Almeida S, Filipe A, Vallée F, Tanguay M, Larouche R, Lainesse A. Comparative bioavailability of two formulations of terbinafine: data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers. Arzneimittelforschung 2004;54(11):757-62.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15612617

34 Portolés A, Almeida S, Terleira A, de Pablo I, Filipe A, Cruz Caturla M, et al. Truncated AUC in the evaluation of fluconazole bioequivalence. A cross-over, randomised, open-label study in healthy volunteers. Arzneimittelforschung 2004;54(11):752-6.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15612616

35 Portolés A, Terleira A, Almeida S, García-Arenillas M, Cruz Caturla M, Filipe A, et al. Bioequivalence study of two formulations of enalapril, at a single oral dose of 20mg (tablets): a randomized, two-way, open-label, crossover study in healthy volunteers. Curr Ther Res Clin Exp 2004 Jan;65(1):34-46.
Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052970/

36 Maya M, Gonçalves N, Silva N, Filipe A, Morais J. Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers. Eur J Drug Metab Pharmacokinet 2003 Apr-Jun;28(2):129-136.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12877571

37 Maya M, Gonçalves N, Silva N, Filipe A, Morais J, Cruz Caturla M, et al. Comparative bioavailability of two immediate release tablets of enalapril/hydrochlorotiazide in healthy volunteers. Eur J Drug Metab Pharmacokinet 2002 Apr-Jun;27(2):91-9.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12064377

38 Maya M, Domingos C, Guerreiro M, Filipe A, Morais J. Comparative bioavailability of two immediate release tablets of cisapride in healthy volunteers. Eur J Drug Metab Pharmacokinet 1998 Jul-Sep;23(3):377-381.
Disponível em (abstract): http://www.ncbi.nlm.nih.gov/pubmed/9842980